참고문헌
- Gendler, S. J., C. A. Lancaster, J. Taylor-Papadimitriou, T. Duhig, N. Peat, J. Burchell, L. Pemberton, E. N. Lalani, and D. Wilson (1990) Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J. Biol. Chem. 265: 15286-15293
- Petrakou, E., A. Murray, C. Rosamund, L. Graves, and M. R. Price (1998) Evaluation of Pepscan analyses for epitope mapping of anti-MUC1 monoclonal antibodies--a comparative study and review of five antibodies. Anticancer. Res. 18:4419-4421
- Denton, G., K. Brady, B. K. Lo, A. Murray, C. R. Graves, O. D. Hughes, S. J. Tendler, C. A. Laughton, and M. R. Price (1999) Production and characterization of an anti-(MUC1 mucin) recombinant diabody. Cancer Immunol Immunother. 48: 29-38 https://doi.org/10.1007/s002620050545
- Berruti, A., M. Tampellini, M. Torta, T. Buniva, G. Gor-zegno, and L. Dogliotti (1994) Prognostic value in predicting overall survival of two mucinous markers: CA 15-3 and CA 125 in breast cancer patients at first relapse of disease. Eur. J. Cancer 30A: 2082-2084
- Martoni, A., C. Zamagni, B. Bellanova, L. Zanichelli, F. Vecchi, N. Cacciari, E. Strocchi, and F. Pannuti (1995) CEA, MCA, CA 15.3 and CA 549 and their combinations in expressing and monitoring metastatic breast cancer: a prospective comparative study. Eur. J. Cancer 31A: 1615-1621
- Price, M. R., S. Briggs, M. J. Scanlon, S. J. B. Tendler, P. E. Sibley, and C. W. Hand (1991) The mucin antigens: what are we measuring? Dis. Markers 9: 205-212
- Dixon, A. R., M. R. Price, C. W. Hand, P. E. Sibley, C. Selby, and R. W. Blarney (1993) Epithelial mucin core antigen (EMCA) in assessing therapeutic response in advanced breast cancer--a comparison with CA15.3. Br. J. Cancer 68: 947-949 https://doi.org/10.1038/bjc.1993.459
- Croce, M. V, M. T. Isla-Larrain, S. O. Demichelis, J. R. Gori, M. R. Price, and A. Segal-Eiras (2003) Tissue and serum MUC1 mucin detection in breast cancer patients. Breast. Cancer Res. Treat. 81: 195-207 https://doi.org/10.1023/A:1026110417294
- Perkins, A. C, I. M. Symonds, M. V. Pimm, M. R. Price, M. L. Wastie, and E. M. Symonds (1993) Immunoscinti-graphy of ovarian carcinoma using a monoclonal antibody (111In-NCRC48) defining a polymorphic epithelial mucin (PEM) epitope. Nucl. Med. Commun. 14: 578-586 https://doi.org/10.1097/00006231-199307000-00011
- Holliger, P. and G. Winter (1997) Diabodies: small bis-pecific antibody fragments. Cancer Immunol. Immunother. 45: 128-130 https://doi.org/10.1007/s002620050414
- Wu, J., J. A. Longmate, G. Adamus, P. A. Hargrave, and E. K. Wakeland (1996) Interval mapping of quantitative trait loci controlling humoral immunity to exogenous antigens: evidence that non-MHC immune response genes may also influence susceptibility to autoimmunity. J. Immunol. 157: 2498-2505
- Shiloach, J. and R. Fass (2005) Growing E. coli to high cell density A historical perspective on method development. Biotechnol. Adv. 23: 345-357 https://doi.org/10.1016/j.biotechadv.2005.04.004
- Zhang, Z. R., D. A. O'Sullivan, and A. Lyddiatt (1999) Magnetically stabilised fluidised bed adsorption: practical benefit of uncoupling bed expansion from fluid velocities in the purification of a recombinant protein from Escherichia coli. J. Chem. Technol. Biotechnol. 74: 270-274 https://doi.org/10.1002/(SICI)1097-4660(199903)74:3<270::AID-JCTB24>3.0.CO;2-X
- Farid, S. S. (2006) Process economics of industrial monoclonal antibody manufacture. J. Chromatogr. B In press
- Lau, J., C. Tran, P. Licari, and J. Galazzo (2004) Development of a high cell-density fed-batch bioprocess for the heterologous production of 6-deoxyerythronolide B in Escherichia coli. J. Biotechnol. 110: 95-103 https://doi.org/10.1016/j.jbiotec.2004.02.001
- Seo, J. H. and J. E. Bailey (1985) Effects of recombinant plasmid content on growth properties and cloned gene product formation in Escherichia coli. Biotechnol. Bioeng. 27: 1668-1674 https://doi.org/10.1002/bit.260271207
- Vyas, V. V., S. Gupta, and P. Sharma (1994) Stability of a recombinant shuttle plasmid in Bacillus subtilis and Es-cherichia coli. Enzyme Microb. Technol. 16: 240-246 https://doi.org/10.1016/0141-0229(94)90049-3
- Lan, J. C., T. C. Ling, G. Hamilton, and A. Lyddiatt (2006) Production of an anti-MUC1 C595 dbFv antibody fragment in recombinant Escherichia coli. Process Biochem. In press
- Eiteman, M. A. and E. Altman (2006) Overcoming acetate in Escherichia coli recombinant protein fermentations. Trends Biotechnol. 24: 530-536 https://doi.org/10.1016/j.tibtech.2006.09.001
- Meyer, H.-R., C. Leist, and A. Fiechter (1984) Acetate formation in continuous culture of Escherichia coli K12 D1 on defined and complex media. J. Biotechnol. 1: 355-358 https://doi.org/10.1016/0168-1656(84)90027-0
- Riesenberg, D., K. Menzel, V. Schulz, K. Schumann, G. Veith, G. Zuber, and W. A. Knorre (1990) High cell density fermentation of recombinant Escherichia coli expressing human interferon alpha 1. Appl. Microbiol. Biotechnol. 34: 77-82
- Yee, L. and H. W. Blanch (1992) Recombinant protein expression in high cell density fed-batch cultures of Escherichia coli. Biotechnology 10: 1550-1556 https://doi.org/10.1038/nbt1292-1550
- Bostrom, M., K. Markland, A. M. Sanden, M. Hedhammar, S. Hober, and G. Larsson (2005) Effect of substrate feed rate on recombinant protein secretion, degradation and inclusion body formation in Escherichia coli. Appl. Microbiol. Biotechnol. 68: 82-90 https://doi.org/10.1007/s00253-004-1855-4